 |
|
Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin
December 03, 2007WESTCHESTER, Ill. - Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition.
The practice parameters were developed by the American Academy of Sleep Medicine's (AASM) Standards of Practice Committee, who appointed a Task Force of content experts to perform a comprehensive review of the medical literature regarding treatment of hypersomnias of central origin, and to grade the strength of evidence for each citation.
The following are highlights of recommendations for the treatment of narcolepsy and other hypersomnias of central origin:
Standards (generally accepted patient-care strategies that reflect a high degree of clinical certainty):
* An accurate diagnosis of a specific hypersomnia disorder of central origin should be established. The evaluation should include a thorough examination of other possible contributing causes of excessive daytime sleepiness.
* Treatment objectives should include control of sleepiness and other sleep related symptoms when present.
* Modafinil is effective for treatment of daytime sleepiness due to narcolepsy.
* Sodium oxybate is effective for treatment of cataplexy, daytime sleepiness, and disrupted sleep due to narcolepsy.
* Tricyclic antidepressants, selective serotonin reuptake inhibitors, venlafaxine, and reboxetine may be effective treatment for narcolepsy.
* Regular follow-up of patients with hypersomnia of central origin is necessary to monitor response to treatment, to respond to potential side effects of medications, and to enhance the patient's adaptation to the disorder.
Guidelines (patient-care strategies that reflect a moderate degree of clinical certainty):
* Amphetamine, methamphetamine, dextroamphetamine, and methylphenidate are effective for treatment of daytime sleepiness due to narcolepsy.
* Scheduled naps can be beneficial to combat sleepiness but seldom suffice as primary therapy for narcolepsy.
* Tricyclic antidepressants, selective serotonin reuptake inhibitors, venlafaxine and reboxetine may be effective treatment for cataplexy.
* Modafinil may be effective for treatment of daytime sleepiness due to multiple sclerosis.
Options (patient-care strategies that reflect uncertain clinical use):
* Sodium oxybate, tricyclic antidepressants, selective serotonin reuptake inhibitors and venlafaxine may be effective for treatment of hypnagogic hallucinations and sleep paralysis.
* Selegiline may be an effective treatment for cataplexy and daytime sleepiness.
* Ritanserin may be effective treatment of daytime sleepiness due to narcolepsy.
* Modafinil may be effective for treatment of daytime sleepiness due to idiopathic hypersomnia and Parkinson disease.
* Modafinil, methylphenidate may be effective for treatment of daytime sleepiness due to myotonic dystrophy.
"Since the publication of the 2000 paper, when the Standards of Practice Committee published a combined review and updated practice parameters on treatment of narcolepsy that included therapies other than stimulants, there have been significant advances concerning the treatment of hypersomnia to justify a practice parameters update," said Timothy I. Morgenthaler, MD, of the Mayo Clinic in Rochester, Minn., one of the committee members. "The AASM expects these guidelines to have an impact on professional behavior, patient outcomes and, possibly, health care costs."
Excessive daytime sleepiness has a significant detrimental impact on psychological, social and vocational function and personal safety, thus adversely affecting quality of life. Sleepiness is an important public health issue among individuals who work in fields where the lack of attention can result in injury to self or others such as transportation and health care.
Narcolepsy is a sleep disorder that causes people to fall asleep uncontrollably during the day. It also includes features of dreaming that occur while awake. Other common symptoms include sleep paralysis, hallucinations and cataplexy. About one out of every 2,000 people is known to have narcolepsy. The chance that you have narcolepsy is higher when a relative also has it. It affects the same number of men and women.
Hypersomnia is characterized by recurrent episodes of excessive daytime sleepiness or prolonged nighttime sleep. Different from feeling tired due to lack of or interrupted sleep at night, persons with hypersomnia are compelled to nap repeatedly during the day, often at inappropriate times such as at work, during a meal, or in conversation. These daytime naps usually provide no relief from symptoms. Patients often have difficulty waking from a long sleep, and may feel disoriented. Other symptoms may include anxiety, increased irritation, decreased energy, restlessness, slow thinking, slow speech, loss of appetite, hallucinations, and memory difficulty. Some patients lose the ability to function in family, social, occupational, or other settings.
On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
The AASM offers the following tips on how to get a good night's sleep:
* Follow a consistent bedtime routine.
* Establish a relaxing setting at bedtime.
* Get a full night's sleep every night.
* Do not go to bed hungry, but don't eat a big meal before bedtime either.
* Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.
* Avoid any rigorous exercise within six hours of your bedtime.
* Make your bedroom quiet, dark and a little bit cool.
* Get up at the same time every morning.
American Academy of Sleep Medicine
Standards (generally accepted patient-care strategies that reflect a high degree of clinical certainty):
* An accurate diagnosis of a specific hypersomnia disorder of central origin should be established. The evaluation should include a thorough examination of other possible contributing causes of excessive daytime sleepiness.
* Treatment objectives should include control of sleepiness and other sleep related symptoms when present.
* Modafinil is effective for treatment of daytime sleepiness due to narcolepsy.
* Sodium oxybate is effective for treatment of cataplexy, daytime sleepiness, and disrupted sleep due to narcolepsy.
* Tricyclic antidepressants, selective serotonin reuptake inhibitors, venlafaxine, and reboxetine may be effective treatment for narcolepsy.
* Regular follow-up of patients with hypersomnia of central origin is necessary to monitor response to treatment, to respond to potential side effects of medications, and to enhance the patient's adaptation to the disorder.
Guidelines (patient-care strategies that reflect a moderate degree of clinical certainty):
* Amphetamine, methamphetamine, dextroamphetamine, and methylphenidate are effective for treatment of daytime sleepiness due to narcolepsy.
* Scheduled naps can be beneficial to combat sleepiness but seldom suffice as primary therapy for narcolepsy.
* Tricyclic antidepressants, selective serotonin reuptake inhibitors, venlafaxine and reboxetine may be effective treatment for cataplexy.
* Modafinil may be effective for treatment of daytime sleepiness due to multiple sclerosis.
Options (patient-care strategies that reflect uncertain clinical use):
* Sodium oxybate, tricyclic antidepressants, selective serotonin reuptake inhibitors and venlafaxine may be effective for treatment of hypnagogic hallucinations and sleep paralysis.
* Selegiline may be an effective treatment for cataplexy and daytime sleepiness.
* Ritanserin may be effective treatment of daytime sleepiness due to narcolepsy.
* Modafinil may be effective for treatment of daytime sleepiness due to idiopathic hypersomnia and Parkinson disease.
* Modafinil, methylphenidate may be effective for treatment of daytime sleepiness due to myotonic dystrophy.
"Since the publication of the 2000 paper, when the Standards of Practice Committee published a combined review and updated practice parameters on treatment of narcolepsy that included therapies other than stimulants, there have been significant advances concerning the treatment of hypersomnia to justify a practice parameters update," said Timothy I. Morgenthaler, MD, of the Mayo Clinic in Rochester, Minn., one of the committee members. "The AASM expects these guidelines to have an impact on professional behavior, patient outcomes and, possibly, health care costs."
Excessive daytime sleepiness has a significant detrimental impact on psychological, social and vocational function and personal safety, thus adversely affecting quality of life. Sleepiness is an important public health issue among individuals who work in fields where the lack of attention can result in injury to self or others such as transportation and health care.
Narcolepsy is a sleep disorder that causes people to fall asleep uncontrollably during the day. It also includes features of dreaming that occur while awake. Other common symptoms include sleep paralysis, hallucinations and cataplexy. About one out of every 2,000 people is known to have narcolepsy. The chance that you have narcolepsy is higher when a relative also has it. It affects the same number of men and women.
Hypersomnia is characterized by recurrent episodes of excessive daytime sleepiness or prolonged nighttime sleep. Different from feeling tired due to lack of or interrupted sleep at night, persons with hypersomnia are compelled to nap repeatedly during the day, often at inappropriate times such as at work, during a meal, or in conversation. These daytime naps usually provide no relief from symptoms. Patients often have difficulty waking from a long sleep, and may feel disoriented. Other symptoms may include anxiety, increased irritation, decreased energy, restlessness, slow thinking, slow speech, loss of appetite, hallucinations, and memory difficulty. Some patients lose the ability to function in family, social, occupational, or other settings.
On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
The AASM offers the following tips on how to get a good night's sleep:
* Follow a consistent bedtime routine.
* Establish a relaxing setting at bedtime.
* Get a full night's sleep every night.
* Do not go to bed hungry, but don't eat a big meal before bedtime either.
* Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.
* Avoid any rigorous exercise within six hours of your bedtime.
* Make your bedroom quiet, dark and a little bit cool.
* Get up at the same time every morning.
American Academy of Sleep Medicine
Narcolepsy Current Events and Narcolepsy News RSSNarcolepsy is an autoimmune disorder, Stanford researcher says
Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy.
Genetic study confirms the immune system's role in narcolepsy
Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night.
Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms
A study in the April 15 issue of the Journal of Clinical Sleep Medicine is the first to assess the effectiveness of treating sleep disorders in adults with a traumatic brain injury (TBI). Results indicate that treatment may result in the objective resolution of the sleep disorder without improvements in daytime sleepiness or neuropsychological function.
Combating weight gain caused by antipsychotic treatments
Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behavioral problems related to dementia.
PET imaging focuses on medication's purported ability to improve mental performance
Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain.
JCSM: A single subjective question can be an effective sleepiness screening tool
A single subjective (SS) question may be an effective screening tool for excessive daytime sleepiness, according to a study published in the April 15 issue of the Journal of Clinical Sleep Medicine (JCSM).
New study in the journal SLEEP finds a high prevalence of eating disorders in narcoleptics
The majority of patients with narcolepsy/cataplexy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features, according to a study published in the March 1 issue of the journal SLEEP.
Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.
2 different neural pathways regulate loss and regain of consciousness during general anesthesia
University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations.
Hormone links sleep, hunger and metabolism, researchers find
While investigating how the hormone orexin might control sleep and hunger, researchers at UT Southwestern Medical Center have discovered, to their surprise, that it activates a protein, HIF-1, long known to stimulate cancerous tumor growth.
More Narcolepsy Current Events and Narcolepsy News Articles
 |
Narcolepsy: A Funny Disorder That's No Laughing Matter by Marguerite J. Utley (Author) This book provides accurate facts about all aspects of narcolepsy, a little-known neurological sleep disorder. It is estimated that 150,000-250,000 people in the U.S. have narcolepsy, but most of those have not yet been diagnosed. In the past, patients have seen an average of five or more physicians over a decade or longer before receiving a correct diagnosis of narcolepsy. As the public becomes better informed and more doctors are entering the field of sleep medicine, people are being diagnosed quicker and at an easlier age. A wealth of information about narcolepsy is available on the internet, but this 166-page book is the most comprehensive, single source of information to be found. In addition to facts, the author relates her personal experiences with all the symptoms... |
 |
Narcolepsy Medical Guide by Qontro Medical Guides (Author) The Narcolepsy Medical Guide is a publication which has been designed to better help readers understand Narcolepsy. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Narcolepsy. The Narcolepsy Medical Guide is highly recommended for those interested in understanding and learning more about Narcolepsy. |
 |
Psychosocial Aspects of Narcolepsy by Meeta Goswami (Editor), Charles P. Pollak (Editor), Felissa L. Cohen (Editor) This groundbreaking book focuses on the impact narcolepsy has on a person’s day-to-day life. It addresses the diagnosis, treatment, and management of narcolepsy with particular emphasis on psychological and social aspects of care. A multidisciplinary team of nationally and internationally respected scientists, researchers, and clinicians discuss the detrimental effects narcolepsy has on interpersonal relationships, employment, education, recreation, and other aspects of everyday life, from driving an automobile to sexual relations. Narcolepsy’s effects on these and other daily activities are often neglected in the study of the disorder. This book brings into focus the personal and social costs of narcolepsy and discusses the often enormous impact that narcolepsy can have on a... |
 |
Narcolepsy (Home Use) Narcolepsy is a chronic neurological disorder caused by the brain's inability to regulate the correct times for sleeping and the correct times to be awake. At various moments throughout the day, people with narcolepsy experience sudden urges to sleep. If the urge becomes overwhelming, they may do so for periods lasting from a few seconds to several minutes. The condition is profoundly disabling, interrupting life's basic day to day activities, including working, driving, even conversing with others. Narcolepsy affects about 1 in every 2,000 Americans. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Aberrations by Penelope Przekop (Author) Twenty-one-year-old narcoleptic Angel Duet knows her father harbors secrets. He loves and protects her, but his suspicious refusal to discuss her mother s death drives Angel to worship an image created from the little history she does have: her father's sketchy stories and her mother's treasured photography, studies of clouds that have hung in the their foyer for more than twenty years. When her father's girlfriend moves in, the photographs come down, and Angel's search for truth becomes an obsession. As she struggles to uncover the past and gain control over the narcolepsy that often fogs her world, Angel descends into a dizzying realm of drugs, adultery, and confused desire that further obscures reality. As Angel begins to expose a history she could never have imagined, she... |
 |
The Official Patient's Sourcebook on Narcolepsy by James N. Parker (Editor), Philip M. Parker (Editor) This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to narcolepsy (also Gelineau's Syndrome; narcoleptic syndrome; paroxysmal sleep; sleep epilepsy), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on narcolepsy. Given patients'... |
 |
Narcolepsy Baby Rhesus (Primary Contributor) |
 |
Narcolepsy:: A Clinical Guide by Meeta Goswami (Editor), S. R. Pandi-Perumal (Editor), Michael J. Thorpy (Editor) This interdisciplinary volume brings together many of the world’s leading clinicians and researchers to discuss current and anticipated developments in the understanding of narcolepsy. The volume is broadly divided into four main sections: Section I: Etiology; Section II: Clinical Considerations; Section III: Psychosocial considerations; and Section IV: Management. The areas covered include findings from research investigations on the genetic predisposition and pathophysiology, psychosocial aspects, and clinical management of narcolepsy by means of pharmacological and non-pharmacological methods. Special attention is paid to the translational aspects of narcolepsy. This volume is suitable for sleep disorders specialists and researchers, psychiatrists, neurologists,... |
 |
Ecotones Duet Sleep Sound Machine, Black by Adaptive Sound Technologies The Ecotones family of Sleep Sound Machines from Adaptive Sound Technologies is designed to provide the most realistic, natural sound environment possible to help people relax and sleep better at night. Each device includes ultra-high quality natural sound recordings for the most realistic listening experience. They use ASTI's patented Adaptive SoundTM Technology that listens and responds to background disturbances. The Ecotones family delivers a relaxing and peaceful environment wherever it is needed. |
 |
The Little Sleep: A Novel by Paul Tremblay (Author) Raymond Chandler meets Jonathan Lethem in this wickedly entertaining debut featuring Mark Genevich, Narcoleptic Detective Mark Genevich is a South Boston P.I. with a little problem: he’s narcoleptic, and he suffers from the most severe symptoms, including hypnogogic hallucinations. These waking dreams wreak havoc for a guy who depends on real-life clues to make his living. Clients haven’t exactly been beating down the door when Mark meets Jennifer Times—daughter of the powerful local D.A. and a contestant on American Star—who walks into his office with an outlandish story about a man who stole her fingers. He awakes from his latest hallucination alone, but on his desk is a manila envelope containing risqué photos of Jennifer. Are the pictures real, and if so, is... |
| © 2010 BrightSurf.com |